Frederic Carsten Schmeel1, Birgit Simon1, Julian Alexander Luetkens1, Frank Träber1, Leonard Christopher Schmeel1, Hans Heinz Schild1, and Dariusch Reza Hadizadeh1
Imaging-based
response assessment to local interventional therapies is essential for further therapy
decisions in patients with advanced malignancies. Therefore, we investigated whether early
post-therapeutic changes in diffusion-weighted MRI using quantifications of the
apparent diffusion coefficient (ADC) could predict the outcome of patients with
liver-dominant metastatic colorectal cancer after radioembolization with 90-Yttrium microspheres (RE). Uni-
and multivariate survival analyses were performed comparing various variables
with potential impact on overall survival. Our results reveal that an increase
in the post-therapeutic minimal ADC remained the strongest and only independent
predictor of overall survival shortly after radioembolization.